trial · primary record
Xanomeline/Trospium Chloride
Schizophrenia
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 472 |
| Primary completion | 2029-03-03 |
| Primary endpoint | Time From Randomization to the First Relapse Event |
| Registry ID | NCT07686263 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:40:32.248Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07686263
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.